NSEGeneral Updates4d ago · 5 Nov 2026, 06:11 pm

General Updates

AstraZeneca Pharma India Limited · ASTRAZEN

✦ AI SummaryMgmt Change

AstraZeneca Pharma India Limited has informed the Exchange about General Updates, specifically the determination of materiality - Details of Key Managerial Personnel.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

AstraZeneca Pharma India Limited has informed the Exchange about General Updates

Attachments (1)

📄

ASTRAZEN_05112026181111_Determination_of_Meteriality_under_Reg_30.pdf

pdf

Download →
View document text
November 5, 2026 The Manager - Listing BSE Limited P J Towers, Dalal Street, Fort Mumbai - 400 001 BSE scrip code: 506820 The Manager - Listing National Stock Exchange of India Limited Exchange Plaza, Bandra – Kurla Complex, Bandra (E) Mumbai - 400 051 NSE symbol: ASTRAZEN Dear Sir/ Madam, Subject: Determination of materiality - Details of Key Managerial Personnel This is to inform that, as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the contact details of the Key Managerial Personnel authorised to determine the materiality of an event and/or information for disclosure to the Stock Exchange(s), with effect from November 9, 2026, are as follows: Sl. No. Name & Designation Contact Details 1. Mr. Praveen Rao Akkinepally Praveen.Akkinepally@astrazeneca.com Managing Director 2. Mr. Atul Tandon Atul.Tandon@astrazeneca.com Chief Financial Officer 3. Ms. Tanya Sanish tanya.sanish@astrazeneca.com Company Secretary Kindly take the above information on record. Thanking you, For AstraZeneca Pharma India Limited Tanya Sanish Company Secretary & Compliance Officer ACS No. A25784